
“Human, you ought to be ashamed” By MichaelH

“Human, you ought to be ashamed” By MichaelH

I’m actually curious now to see if lemon juice would kill foot odor/bacteria. Will report back in one week. comments/banter.

In honour of Star Wars Day, which is this Sunday – May the Fourth be with you, always.
Here are more Star Wars comics!

More Godzilla. Looking forward to the new movie!

My Godzilla theme continues! I guess I must be excited about the new movie!
This one’s dedicated to Michael and Carina, who are both celebrating birthdays this weekend. Happy birthday, you two!
“I don't know what the language of the year 2000 will look like, but I know it will be called Fortran.” —Tony Hoare, winner of the 1980 Turing Award, in 1982.
Take a tour through the research laboratories at any university physics department or national lab, and much of what you will see defines “cutting edge.” “Research,” after all, means seeing what has never been seen before—looking deeper, measuring more precisely, thinking about problems in new ways.
A large research project in the physical sciences usually involves experimenters, theorists, and people carrying out calculations with computers. There are computers and terminals everywhere. Some of the people hunched over these screens are writing papers, some are analyzing data, and some are working on simulations. These simulations are also quite often on the cutting edge, pushing the world’s fastest supercomputers, with their thousands of networked processors, to the limit. But almost universally, the language in which these simulation codes are written is Fortran, a relic from the 1950s.

Vibram has settled a class-action lawsuit that accused the company of making false and unsubstantiated claims about the health benefits of its Vibram FiveFingers footwear, according to a report Tuesday from Runner's World. The company will put $3.75 million into an escrow account to pay out settlements to class members and will remove all claims that its products either strengthen muscles or reduce injuries—unless it comes up with proof.
Vibram was one of the driving forces behind the "barefoot" or "minimalist" running trend. Claims circulated that this style of running made athletes less prone to injury, made them more efficient, and strengthened muscles in the foot and lower leg that were otherwise made soft and ineffectual by modern, cushy running shoes. The minimalist shoes also enjoyed popularity among the finicky tech set, often adorning the feet of Google co-founder Sergey Brin and appearing recently in the satirical HBO show Silicon Valley.
Whether running barefoot is actually superior to using normal running shoes has been increasingly called into question over the last few years. While early studies showed that the barefoot style could reduce impact in areas like knees that are prone to strain, later studies found that the strain simply shifted to other parts of the leg and foot. Barefoot running is not necessarily better—just different. In response, Valerie Bezdek filed her class-action suit against Vibram in Massachusetts in March 2012.
Matt Peckham, writing for Time:
Nintendo’s problem is that it’s in that deadliest of platform catch-22s, where you need a slew of standout, signature games to make your case, leveraged by third-party support for all of the triple-A multi-platform titles. The company has too few of the former and a shrinking dearth of the latter at this point. Third parties have either abandoned the system or failed to sign up for duty in the first place, their worries doubtless confirmed for the second cycle running with these latest fiscal results.
NYTimes: Two teams of scientists published studies on Sunday showing that blood from young mice reverses aging in old mice, rejuvenating their muscles and brains. As ghoulish as the research may sound, experts said that it could lead to treatments for disorders like Alzheimer’s disease and heart disease.
The key papers are here and here and here. Some of the papers are pointing to a specific protein but the last paper suggests that simple transfusions also work and that raises a number of issues of public policy. As Derek Lowe notes:
Since blood plasma is given uncounted thousands of times a day in every medical center in the country, this route should have a pretty easy time of it from the FDA. But I’d guess that Alkahest is still going to have to identify specific aging-related disease states for its trials, because aging, just by itself, has no regulatory framework for treatment, since it’s not considered a disease per se.
…You also have to wonder what something like this would do to the current model of blood donation and banking, if it turns out that plasma from an 18-year-old is worth a great deal more than plasma from a fifty-year-old. I hope that the folks at the Red Cross are keeping up with the literature.
Albener PessoaI'm the second type

There are two types of people…
Albener PessoaLooks interesting. Has anyone read this ?